MoneyWorks4Me

Unjha Formulations - Quaterly Results

10 Feb 2023 Evaluate
The sales declined to Rs. 32.13 millions for the December 2022 quarter as compared to Rs. 39.55 millions during the corresponding quarter last year.The Net Loss for the quarter ended December 2022 is Rs. -0.95 millions as compared to Net Profit of Rs. 0.20 millions of corresponding quarter ended December 2021Operating profit Margin for the quarter ended December 2022 slipped to -0.74% as compared to 0.42% of corresponding quarter ended December 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 32.13 39.55 -18.76 103.17 99.90 3.27 143.51 101.72 41.08
Other Income 0.15 0.34 -55.88 0.25 0.66 -62.12 0.00 0.00 0.00
PBIDT -0.74 0.42 -276.19 5.67 3.85 47.27 5.09 3.58 42.18
Interest 0.03 0.03 0.00 0.11 0.13 -15.38 1.32 1.73 -23.70
PBDT -0.77 0.39 -297.44 5.56 3.72 49.46 3.77 1.85 103.78
Depreciation 0.18 0.19 -5.26 0.57 0.59 -3.39 0.76 0.81 -6.17
PBT -0.95 0.20 -575.00 4.99 3.13 59.42 3.01 1.04 189.42
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.95 0.20 -575.00 4.99 3.13 59.42 2.54 1.04 144.23
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) -2.30 1.06 -316.88 5.50 3.85 42.60 3.55 3.52 0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..